Detalhe da pesquisa
1.
Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination.
J Infect Dis
; 228(6): 734-741, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210741
2.
Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial.
J Infect Dis
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37970668
3.
Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373.
N Engl J Med
; 388(9): 857-859, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734884
4.
Changes in the gut microbiome community of nonhuman primates following radiation injury.
BMC Microbiol
; 21(1): 93, 2021 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781201
5.
Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and ß) against Zika virus.
J Med Virol
; 90(1): 8-12, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851097
6.
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
J Virol Methods
; 327: 114945, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649070
7.
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.
medRxiv
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293205
8.
A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2-Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
Microorganisms
; 12(3)2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543552
9.
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial.
Lancet Infect Dis
; 24(6): 581-593, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460525
10.
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines.
Expert Rev Vaccines
; 22(1): 620-628, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386785
11.
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
Microorganisms
; 11(2)2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36838333
12.
A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.
Microorganisms
; 11(7)2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37512961
13.
Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373.
Vaccine
; 41(29): 4280-4286, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271706
14.
XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants.
Sci Rep
; 13(1): 19176, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932354
15.
Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults.
Vaccine
; 41(41): 5965-5973, 2023 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652823
16.
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Sci Rep
; 13(1): 16579, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789040
17.
Reshaping an Acyclic Nucleoside Phosphonate into a Selective Anti-hepatitis B Virus Compound.
J Med Chem
; 65(13): 9396-9417, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35754374
18.
Introduction of a cyano group at the 2-position of an (R,S)-3-hydroxy-2-(phosphonomethoxy)propyl (HPMP) derivative of thymine elicits selective anti-HBV activity.
RSC Med Chem
; 12(5): 804-808, 2021 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34124679
19.
SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes.
Microorganisms
; 9(8)2021 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34442823
20.
SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs.
Am J Trop Med Hyg
; 103(1): 18-21, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32406369